Search
Saul Ewing hosted a webinar delving into the implications of Artificial Intelligence (AI) use at academic institutions. Universities are increasingly integrating AI into various aspects of their operations, raising critical legal, compliance, and ethical questions. With AI’s growing adoption within...
Saul Ewing attorneys Brandon Sherman and John Marty will be speaking at the Fame ( Financial Aid & School Management) Conference on May 2, 2024. The Fame Conference is the premier, anticipated event for higher education professionals around the country. They offer an array of informative...
Intellectual Property 101 / Copyrights, Patents, and Trademarks…Oh My! Thomas Edison. Henry Ford. Steve Jobs. These three household names revolutionized modern society through the protections afforded to their intellectual property by U.S. patent laws. Traditionally a copyright attaches when the...
This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for the calendar year ended 2023 and is intended to serve as a focused resource highlighting changes in disclosure requirements and points of emphasis for the Securities and Exchange...
January 26, 2024 - With AI poised to reshape the practice of law and businesses in every industry, Saul Ewing is pleased to partner with the ABA’s Intellectual Property Litigation Committee in forming the AI Subcommittee. The AI Subcommittee will monitor legal and technological developments in this...
Sandy Bilus, a member of the Ethics Committee and Saul Ewing's Deputy General Counsel, will be speaking at the SCCE Virtual Higher Education Compliance Conference on October 25, 2023. Privacy Law: Year in Review Speakers: Alexander Bilus and Kenneth Liddle Understand changes to privacy law at all...
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi , 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...